A
Arrivent Biopharma Inc
NASDAQ:AVBP
Arrivent Biopharma Inc
NASDAQ:AVBP
Price:
22.86
USD
0.22%
Market Closed
Market Cap:
$943.7m
Balance Sheet
Balance Sheet Decomposition
Arrivent Biopharma Inc
Arrivent Biopharma Inc
Balance Sheet Decomposition is not available for
Arrivent Biopharma Inc
Arrivent Biopharma Inc
Balance Sheet
Arrivent Biopharma Inc
Arrivent Biopharma Inc
Currency: USD
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
37
|
163
|
150
|
74
|
46
|
|
| Cash |
37
|
163
|
150
|
74
|
46
|
|
| Short-Term Investments |
0
|
0
|
0
|
145
|
267
|
|
| Total Receivables |
0
|
1
|
1
|
1
|
0
|
|
| Other Current Assets |
5
|
19
|
9
|
8
|
20
|
|
| Total Current Assets |
43
|
183
|
160
|
227
|
333
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
48
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
3
|
0
|
0
|
|
| Total Assets |
43
N/A
|
183
+325%
|
163
-11%
|
275
+69%
|
333
+21%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
3
|
5
|
4
|
6
|
|
| Accrued Liabilities |
2
|
5
|
7
|
13
|
20
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
8
|
12
|
17
|
26
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
8
+360%
|
12
+41%
|
17
+46%
|
26
+50%
|
|
| Equity | ||||||
| Common Stock |
90
|
260
|
304
|
0
|
0
|
|
| Retained Earnings |
52
|
89
|
158
|
238
|
405
|
|
| Additional Paid In Capital |
3
|
3
|
5
|
496
|
712
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
41
N/A
|
174
+323%
|
151
-13%
|
258
+70%
|
307
+19%
|
|
| Total Liabilities & Equity |
43
N/A
|
183
+325%
|
163
-11%
|
275
+69%
|
333
+21%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
32
|
32
|
32
|
34
|
42
|
|
Switch to:
Switch to:
See Also
Discover More
